What is the address of Dr. Nele Deprez – gastro-enterologie?

The registered office of Dr. Nele Deprez – gastro-enterologie is located at Dentergemstraat 14, 8700 Tielt.

Is Dr. Nele Deprez – gastro-enterologie still active?

Yes. According to the CBE (30 September 2026) Dr. Nele Deprez – gastro-enterologie is active, legal situation “Normale toestand”, started on 4 March 2022.

Is Dr. Nele Deprez – gastro-enterologie registered on Peppol?

Yes, Dr. Nele Deprez – gastro-enterologie is registered on the Peppol network with ID 0208:0782899767.

What is the enterprise number of Dr. Nele Deprez – gastro-enterologie?

The enterprise number of Dr. Nele Deprez – gastro-enterologie is BE0782899767.

When was Dr. Nele Deprez – gastro-enterologie founded?

Dr. Nele Deprez – gastro-enterologie was founded on 4 March 2022.

Who are the directors of Dr. Nele Deprez – gastro-enterologie?

According to the 2025 annual accounts, the directors of Dr. Nele Deprez – gastro-enterologie are: Nele DEPREZ.

Is Dr. Nele Deprez – gastro-enterologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 4 March 2022; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Nele Deprez – gastro-enterologie make in 2025?

Dr. Nele Deprez – gastro-enterologie posted a profit after taxes of € 251,281 in financial year 2025.

What is the revenue of Dr. Nele Deprez – gastro-enterologie?

As a small company, Dr. Nele Deprez – gastro-enterologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 339,100.

Dr. Nele Deprez – gastro-enterologie (Private Limited)

Dossier Dr. Nele Deprez – gastro-enterologie, printed on 30 September 2026 from databakkes.be/en/0782899767/dr-nele-deprez-gastro-enterologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 44 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Dr. Nele Deprez – gastro-enterologie from Tielt, company number BE0782899767, closed financial year 2025 with a result of € 251,281 after tax. For that financial year Dr. Nele Deprez – gastro-enterologie recorded a gross margin of € 339,100 and equity of € 1,000. Compared with financial year 2024, the result moved from € 191,317 to € 251,281. Profitable, and profit is growing. The buffer shrank hard: equity is 100 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.

What it is worth Shrank hard

€ 1,000

▼ € 376,284 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 251,281

▲ 31% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 122,370

▼ 52% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 627,565 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 5,058

▼ 45% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2,250

▲ 109% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 41,093

▼ 35% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 67,940 Gross margin 2022: € 67,940 First fiscal year in the series	€ 178,747 Gross margin 2023: € 178,747 ▲ 163% vs 2022 (€ 67,940) Favourable step	€ 255,778 Gross margin 2024: € 255,778 ▲ 43% vs 2023 (€ 178,747) Favourable step	€ 339,100 Gross margin 2025: € 339,100 ▲ 33% vs 2024 (€ 255,778) Favourable step	▲ 33%
Profit after taxes	€ 51,200 Profit after taxes 2022: € 51,200 First fiscal year in the series	€ 133,767 Profit after taxes 2023: € 133,767 ▲ 161% vs 2022 (€ 51,200) Favourable step	€ 191,317 Profit after taxes 2024: € 191,317 ▲ 43% vs 2023 (€ 133,767) Favourable step	€ 251,281 Profit after taxes 2025: € 251,281 ▲ 31% vs 2024 (€ 191,317) Favourable step	▲ 31%
Equity	€ 52,200 Equity 2022: € 52,200 First fiscal year in the series	€ 185,966 Equity 2023: € 185,966 ▲ 256% vs 2022 (€ 52,200) Favourable step	€ 377,284 Equity 2024: € 377,284 ▲ 103% vs 2023 (€ 185,966) Favourable step	€ 1,000 Equity 2025: € 1,000 ▼ € 376,284 vs 2024 (€ 377,284) Unfavourable step	▼ € 376,284
Total debts	€ 26,283 Total debts 2022: € 26,283 First fiscal year in the series	€ 46,301 Total debts 2023: € 46,301 ▲ 76% vs 2022 (€ 26,283) Unfavourable step	€ 65,258 Total debts 2024: € 65,258 ▲ 41% vs 2023 (€ 46,301) Unfavourable step	€ 296,227 Total debts 2025: € 296,227 ▲ € 230,968 vs 2024 (€ 65,258) Unfavourable step	▲ € 230,968
Cash	€ 42,536 Cash 2022: € 42,536 First fiscal year in the series	€ 158,337 Cash 2023: € 158,337 ▲ 272% vs 2022 (€ 42,536) Favourable step	€ 254,690 Cash 2024: € 254,690 ▲ 61% vs 2023 (€ 158,337) Favourable step	€ 122,370 Cash 2025: € 122,370 ▼ 52% vs 2024 (€ 254,690) Unfavourable step	▼ 52%
Retained profit	€ 51,200 Retained profit 2022: € 51,200 First fiscal year in the series	€ 184,966 Retained profit 2023: € 184,966 ▲ 261% vs 2022 (€ 51,200) Favourable step	€ 376,284 Retained profit 2024: € 376,284 ▲ 103% vs 2023 (€ 184,966) Favourable step	€ 0 Retained profit 2025: € 0 ▼ 100% vs 2024 (€ 376,284) Unfavourable step	▼ 100%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 627,565 Dividend 2025: € 627,565 Unchanged (€ 0) Unchanged
Balance sheet total	€ 78,483 Balance sheet total 2022: € 78,483 First fiscal year in the series	€ 232,268 Balance sheet total 2023: € 232,268 ▲ 196% vs 2022 (€ 78,483) Unchanged	€ 442,542 Balance sheet total 2024: € 442,542 ▲ 91% vs 2023 (€ 232,268) Unchanged	€ 297,227 Balance sheet total 2025: € 297,227 ▼ 33% vs 2024 (€ 442,542) Unchanged	▼ 33%

Key figures of Dr. Nele Deprez – gastro-enterologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Nele Deprez – gastro-enterologie?

What happened at Dr. Nele Deprez – gastro-enterologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 2, 2026 New annual accounts for financial year 2025: profit of € 251,281 (▲ 31% vs 2024). Source: NBB ↗
May 1, 2022 New establishment in Gent. KBO
Mar 4, 2022 Start of the company according to the CBE. KBO

In short

From € 51,200 profit in 2022 to € 251,281 profit in 2025.

Paid € 203,575 in corporate taxes since 2022.

Best year ever: 2025, with € 251,281 profit.

Paid out € 627,565 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Nele Deprez – gastro-enterologie? We notify you, reason included.

Follow Dr. Nele Deprez – gastro-enterologie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit